# Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer

> **NCT03665571** · — · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Receptor specific activation method

## Key facts

- **NCT ID:** NCT03665571
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2018-10
- **Final completion:** 2019-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665571, "Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03665571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*